Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Ex Input:
Paragraph: Unions and professional groups for such employees say those jobs often are lower priority when budgets are tight, but their absence can have profound effects on student learning and teachers’ work. They contend support staff is vital to properly address everyday student issues such as physical and mental health problems or homelessness. In Chicago, the nation’s third-largest school district, the teachers who have been out on strike since last Thursday are seeking commitments for support staff hiring alongside other demands including higher pay and affordable housing citywide. The demands are part of the union’s “social justice” agenda. Bridget Nelson, a social sciences teacher at a magnet high school in Chicago, said her school is lucky to have a nurse most days but a social worker still is responsible for more than 2,000 students. “Adolescence is a challenging time, and we worry about depression and stress like a lot of educators,” Nelson said. “Some students have support at home, but others don’t. They should have support at school to help give them what they need.” The support-staff issue has come up elsewhere in spring protests by thousands of educators in North Carolina and South Carolina; in Minnesota, where a state survey recently found an increase in students’ mental and emotional health concerns; and in strikes in California, where teachers won promises for hundreds of additional nurses and more counselors in Los Angeles schools and more psychologists and special education instructors in Oakland. Shortages are causing problems in schools across the country, said Melissa Cropper, president of the Ohio Federation of Teachers. While discussing labor unions on a visit this month to a government class in an urban Ohio high school, Cropper said she asked the students what they would want prioritized in negotiations. A girl who had attempted suicide answered first: a counselor. Another student wanted a nurse. “We’ve got kids who are dealing with thinking about committing suicide or coming to school hungry or watched a domestic abuse situation over the weekend,” Cropper said. “We can’t possibly begin to think that we’re going to teach them something that’s going to stick with them until we’ve dealt with these other issues.” Most teachers don’t have specific training to tackle those sorts of concerns, so they’re advocating for schools to add more colleagues who do, American Federation of Teachers President Randi Weingarten said. The American School Counselor Association recommends one counselor for every 250 students but has found the average ratio to be nearly double that. The National School Nurses Association’s most recent estimates, from a study published early last year, indicated less than 40% of schools had a full-time nurse and about a quarter didn’t employ one at all. In those cases, teachers may have to assess and address issues such as gym class injuries, and preventive care can dwindle, said Donna Mazyck, the executive director of the nurses association. At John Tartan Elementary School in North Las Vegas, an assistant trained in basic first aid often handles minor injuries and distributes basic medications because the nurse splits duty at multiple schools, said Marie Neisess, a veteran teacher and reading specialist there. The school of 400-plus students also has a counselor, a social worker and a psychologist, but they struggle to keep up with the needs of the student body, which includes children facing challenges such as severe behavioral problems, foster care or a parent’s incarceration, she said. “We’re all kind of putting Band-Aids on the very big problem that we have here,” Neisess said. In Chicago, Mayor Lori Lightfoot had campaigned with an education plan that included staffing schools with full-time nurses, social workers and librarians, and enabling students to get mental health services. The district has committed to hiring more nurses, social workers and support staff but objected to making that part of the teachers’ contract. The union also has expressed concern about the various roles counselors are expected to fill, including as substitute teachers and lunchroom help, and asked for contract language that spells out that people will only be asked to do the jobs for which they are hired. Pushing for something enforceable in writing makes sense to Matt Mandel, a middle-school English teacher in the Philadelphia School District, who said the local union there has fought to have a nurse and counselor at each school. “In these urban districts like Philadelphia and Chicago, our kids need more,” Mandel said, “and we always find ways to justify giving them less.” ___ Associated Press reporter Kathleen Foody in Chicago contributed to this report. Claim: Chicago teachers’ strike highlights support staff shortages.

Ex Output:
Demands by striking Chicago teachers for more nurses, librarians and social workers are highlighting concerns that resonate in high-poverty school districts nationwide, where shortages of support staff leave educators feeling stretched.


Ex Input:
Paragraph: "Atlanta Mayor Kasim Reed has made no secret of wanting to close the homeless shelter at Peachtree and Pine streets. Reed, who has been active in downtown’s post-Recession resurgence, says he’ll push for the city to acquire the property through eminent domain and turn it into a police precinct and fire station. Health concerns are a major reason for closing the Peachtree-Pines shelter, Reed said during a lunchtime speech to Atlanta’s Commerce Club on Tuesday, Aug. 11. ""Peachtree and Pine is one of the leading sites for tuberculosis in the nation,"" he told the crowd. Reed said top officials with the Centers for Disease Control and Prevention recently asked to meet with him and ""laid out how tuberculosis cases, not in Georgia, but across America, are being traced back to Peachtree and Pine."" Could Peachtree-Pine, billed as the largest homeless shelter in the Southeast, be a leading site for tuberculosis in the nation? PolitiFact decided to do some checking. First a little background. The homeless are prime candidates for tuberculosis because they typically have greater exposure to cold weather, are in crowded conditions when they stay in shelters and lack proper nutrition and medical care. That means shelters, such as Peachtree-Pine, have to be vigilant to avoid becoming breeding grounds for TB, which is spread person to person through the air and caused by the bacteria Mycobacterium tuberculosis. TB normally attacks the lungs, but also can strike the kidney, spine, brain or another body part. In most cases, tuberculosis is treatable and curable, although people can die if they don’t receive the proper treatment. Most people live with the bacteria, or latent TB infection, without feeling sick or showing symptoms. In 2014, 9,412 new tuberculosis cases were reported in the U.S., 334 in Georgia, according to the CDC. A new drug-resistant strain of TB was discovered in 2008 at the shelter at Peachtree and Pine, which is run by the Metro Atlanta Task Force for the Homeless. The strain was labeled G05625 TB by the CDC. The research To fact check Reed’s statement, we reached out to Fulton County government, the CDC, the mayor’s office and the Georgia Department of Public Health, as well as shelter management. Anita Beaty, Peachtree-Pine’s executive director, rejects Reed’s assessment of the shelter and says it is ""100 percent compliant"" with CDC protocol for spotting, treating and avoiding the spread of TB. She said Reed and the business community have conspired for years to force the shelter to close so they can take over its prime location, just south of Midtown and in sight of the Fox Theatre. Tuberculosis has been a worry at all Atlanta and Fulton County shelters, not just Peachtree-Pine, for years. But alarm bells apparently really started going off after an uptick in TB cases last year. ""At a time when the incidents of tuberculosis has been declining across the metropolitan Atlanta area and the rest of Georgia, it has actually increased in Fulton County,"" Brenda Fitzgerald, commissioner of the Georgia Department of Public Health, wrote Fulton County Commission Chair John Eaves in April. A month later, officials with the Centers for Disease Control and Prevention were sitting down for the first of two meetings with Reed about the ongoing TB problem generally, and Peachtree-Pine specifically. ""Our inability to control (the Peachtree-Pine) outbreak has led to infections in multiple other states,"" Philip A. LoBue and Jonathan Mermin, doctors with the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, wrote Reed after they met in May. Based on interviews, data and documents that PolitiFact reviewed, here’s a summary of the major points. -- Since 2008, new cases of the drug-resistant strain of TB that originated at the Peachtree-Pine shelter have turned up in metro Atlanta and Georgia as well as eight other states -- Alabama, California, Florida, Illinois, New York, North Carolina, Pennsylvania and South Carolina. (Genotype evidence, similar to a fingerprint, exists for every strain of TB, and that’s how every new case of G05625 in the state and nation can be traced to the Peachtree-Pine shelter. Similarly, that’s how the Ebola outbreak in west Africa in 201, was traced back to a 2-year-old from a small village in Guinea who died in 2013 and who became known around the world as Patient Zero.) -- At Fulton County’s four shelters, the number of TB cases rose by 230 percent, from 13 in 2013 to 43 in 2014. Twenty-two of the 43 cases, or slightly more than 50 percent, were at Peachtree-Pine. (The CDC defines a large outbreak as being 10 or more cases, CDC spokesman Brian Katzowitz said.) -- The number of drug-resistant G05625 tuberculosis cases, those linked to Peachtree-Pine, grew 10-fold from 2013 to 2014, from two to 23. -- Fulton County accounted for 82 percent of all cases of that strain of tuberculosis in Georgia and 69 percent of all cases of the strain in the United States. -- At least four clients of the Peachtree-Pine shelter, according to Fitzgerald, have died of tuberculosis since early 2014. In her letter to Eaves, Fitzgerald said, public health researchers identified the homeless shelter at the corner of Peachtree and Pine Streets ""as a major source of the current outbreak. ""If it [tuberculosis]  gains a foothold in the community, then the cost in healthcare and human suffering will be incalculable,"" she wrote. Jessica A. Corbitt-Dominguez, director of external affairs for Fulton County government, said Fulton health workers, in conjunction with officials from the Georgia Department of Public Health and CDC, responded to the outbreak with an aggressive campaign of education, testing and treatment. Anyone with active disease was relocated from the shelters while in treatment under the supervision of Fulton Health and Wellness. The county set up special teams that make daily visits to shelters to perform screenings and administer medicines, Corbitt-Dominguez said. In June 2015, the county health department also signed memorandums of understanding (MOUs) with four shelters, including Peachtree and Pine. This was considered a significant step since a lack of administrative controls and protocols is considered a likely contributor to the spread of TB. As of this month, the number of 2015 confirmed TB cases at Fulton homeless shelters is 13, Corbitt-Dominguez said. Beaty’s attorney last week provided reporters with a certificate showing the shelter is fully in compliance with the CDC’s TB protocol, and Beaty told PolitiFact ""it’s ludicrous to think we wouldn’t be on it."" Corbitt-Dominguez confirmed that the shelter has never been cited by the county, although Eaves has said there have been concerns about the shelter’s TB safeguards. In a letter to Fitzgerald, he wrote that the shelter’s administration ""routinely exhibits sub-optimal administration of the procedures required to control the spread of this disease."" Beaty said Reed’s statement makes clear he ""is just not getting good information."" ""We have been cleared by Fulton County, which is on site every day to monitor. And we’ve got 100 percent clearance from the CDC’s requirements,"" she said. ""We resent those easy headlines that have no basis in fact and that marginalize homeless people in our facilities."" Tom Andrews, president of the non-profit Mercy Care, which operates 14 clinics, some associated with shelters, said the strain of TB originating at Peachtree-Pine has to be a major concern. Since it is medicine-resistant, it requires a more expensive and longer treatment program, Andrews said. The CDC estimates that the costs of treating a person with TB increases with greater resistance. Direct costs in 2010 U.S. dollars average from $17,000 to treat drug-susceptible TB to $430,000 to treat the most drug-resistant form, according to the agency’s website. So is it a national leader in TB? We asked the mayor’s office for evidence to back up Reed’s statement that Peachtree-Pine ""is one of the leading sites for tuberculosis in the nation."" Anne Torres, his spokeswoman, provided us copies of the letters from Fitzgerald and the doctors, as well as a highly technical report from the CDC. We reached out to the CDC. A spokesperson said agency officials would not comment on the mayor’s public statements. CDC officials also would not identify the states where they said the TB strain from Peachtree-Pine had spread. We were able to obtain that list from the Georgia Department of Public Health, as well as the number of cases of G05625 strain TB in each state from 2008 to 2014. The most were in Florida (14), followed by California (8) and North Carolina and Alabama (2 each). New York, Illinois, Pennsylvania and South Carolina each reported one case in the five years -- for a total of 30 in the eight states in five years. But do 30 cases over a several-year period raise Peachtree-Pine to a leading site of TB in the nation? We posed that question to Philip Hopewell, a leading tuberculosis expert and professor of medicine at the University of California, San Francisco. ""Peachtree and Pine is clearly  a major site for transmission of Mycobacterium tuberculosis, and it may be one of the leading sites in the nation,"" Hopewell said. ""However, there are not data from every such facility in the country,"" he added. ""To say that the Atlanta facility is one of the leading sites in the country -- it probably is -- implies that there are data with which to compare the Atlanta facility. Thus, strictly speaking, what he said can't be backed with evidence. Even so, I wouldn't fault the mayor for saying this."" Our ruling Mayor Kasim Reed said ""Peachtree and Pine is one of the leading sites for tuberculosis in the nation."" Thirty cases of a medicine-resistant strain of TB in eight states have been traced back to the shelter at Peachtree and Pine. The shelter also had a large share of the cases in a recent TB outbreak in Fulton County and four TB deaths, according to state data. CDC officials clearly believe it’s a concern, but a leading tuberculosis expert says there’s a dearth of comparative data." Claim: Peachtree and Pine is one of the leading sites for tuberculosis in the nation.

Ex Output:
"Mayor Kasim Reed said ""Peachtree and Pine is one of the leading sites for tuberculosis in the nation."" Thirty cases of a medicine-resistant strain of TB in eight states have been traced back to the shelter at Peachtree and Pine. The shelter also had a large share of the cases in a recent TB outbreak in Fulton County and four TB deaths, according to state data. CDC officials clearly believe it’s a concern, but a leading tuberculosis expert says there’s a dearth of comparative data."


Ex Input:
Paragraph: While the story looks at genetic tests for prescribing psychiatric drugs broadly, it also uses one test in particular as a focal point. The story notes that this test, called GeneSight, cost one patient $3,800. The story also notes that GeneSight is covered by Medicare. Those are great points to make in a story like this one. However, since the story also notes that there are a lot of other, similar tests on the market, it would have been good to tell readers a little bit more about cost. Is $3,800 about average for testing costs? Is there a range that these tests fall into? Do other insurers pay for GeneSight? The story would have been stronger if it had touched on these issues. We would have liked to see more detail about the company-funded studies mentioned, especially sample size and the odds ratios or degree of benefit. It is easy and tempting to discredit studies because they are company-funded, but this does not necessarily mean they are wrong — simply that we should proceed with caution in interpreting them. And it’s true that in many cases, the company is the only group interested in investing the time/money to do the necessary research. With that being said, the story does note that “Finding a test to more precisely target treatment could help troubled people find help more quickly, cut down on side effects, and save money.” And, when discussing GeneSight in particular, the story points to “company-funded studies showing that when [patients with depression] took the medications recommended by the test, they had fewer symptoms after eight weeks compared with patients who did not use the test.” We’ll award a Satisfactory and leave the suggestions for next time. This area could have been stronger. The story begins with an anecdote about a patient who was prescribed a drug based in part on the results of a genetic test. That patient became suicidal within three weeks and checked himself into a mental hospital. That sort of story tells readers very little about risks associated with these genetic tests, precisely because it is anecdotal — and there was very little else in the story about potential harms. For example, the story quotes one researcher as saying that claims about such genetic tests are “not harmless and may be quite dangerous.” But the story doesn’t tell us what that means. Why aren’t these claims harmless? Why may they be dangerous? We suspect that the biggest harm here is in the high cost of the test. But what if the test is wrong? It might also cause delays in finding the “right” drug for patients — especially if the genetic test takes time to run and if doctors weigh the test results over clinical judgment or other factors, leading to poorer decisions. The focus of the story is on quality of evidence. It emphasizes the lack of independently-funded studies that have evaluated the efficacy of these genetic tests. Based on a review by the New England Center for Investigative Reporting, “virtually all the evidence that these psychiatric tests work is based on limited studies funded by the companies themselves or researchers they fund, including all five studies used to promote GeneSight on the company’s website.” It would have been good to put some numbers there — “virtually all the evidence” is a somewhat vague description — but we think it does address the Quality of Evidence question in a meaningful way. Worth noting: an annotated version of this story that appeared on the New England Center for Investigative Reporting’s site includes links to supporting information that is of interest. It would have been good if the version of the story that appeared in the Globe had let readers know that the annotated version (and supporting documents) were available. No disease mongering here. A very strong point for the story. It quotes multiple industry and expert sources, with industry sources clearly identified. The story looks at the field of genetic testing to identify psychiatric drugs most likely to be effective to treat specific mental conditions in a given patient. The alternative to using such testing is for psychiatrists to prescribe drugs based on their diagnosis, which is often determined by symptoms. The story doesn’t state this explicitly, and that would have been useful. But the story does note that psychiatry does have “a lack of definitive tests for conditions and treatments alike,” and that doctors often take a “trial-and-error approach to medications.” We think the story did enough here to earn a Satisfactory rating. The story makes clear that many of these tests are currently available. The story notes that “Genetic tests to identify the most effective psychiatric drugs are the hot new technology in the race to create personalized treatments based on people’s DNA” and that “[m]ore than 600,000 of these tests have likely been administered in the last three years.” While it may have been nice to mention that genetic testing is done in some other fields (eg. to determine breast cancer risk) to provide context, the story does enough to earn a Satisfactory rating. This work doesn’t appear to be based on a news release at all — and even if it were, it clearly goes far beyond anything a news release might include. Claim: Genetic tests for psychiatric drugs spur hope, doubts

Ex Output:

This story, originally reported by the New England Center for Investigative Reporting and published in partnership with the Boston Globe, describes the history and ethical implications of a loophole allowing genetic tests to bypass FDA approval before doctors prescribe them. Specifically, it outlines concerns regarding the use of genetic testing to help psychiatrists identify which drugs may work best for a patient with mental illness. The story evaluates the research that genetic testing companies use to demonstrate the effectiveness of their tests — and reports that most of these studies are funded or conducted by the companies themselves. The story makes clear that using these genetic tests to guide decisions on prescribing drugs poses risks for patients. The article overall is very well-researched and covers an emerging and important topic. According to the CDC, approximately 25 percent of U.S. adults have some form of mental illness. Finding the right drug and dose for treating a mental illness can be time-consuming — and mentally, physically and emotionally exhausting for both patients and their loved ones. As a result, the idea of using a genetic test to identify drug treatments that are most likely to be effective is incredibly appealing for all concerned. However, it’s important to recognize the limitations of the current research supporting such testing. The tests are costly and may not offer any benefit. The tests may slightly help doctors pick the right drug more quickly, or they may not, but the drugs that are picked after the genetic tests are done are subject to the same scrutiny as always.